These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 2464699)
21. A phase II study of ifosfamide and cisplatin chemotherapy for metastatic or relapsed carcinoma of the cervix. Coleman RE; Clarke JM; Slevin ML; Sweetenham J; Williams CJ; Blake P; Calman F; Wiltshaw E; Harper PG Cancer Chemother Pharmacol; 1990; 27(1):52-4. PubMed ID: 2245492 [TBL] [Abstract][Full Text] [Related]
22. A phase II evaluation of cisplatin, bleomycin, and mitomycin-C in patients with recurrent squamous cell carcinoma of the cervix. Hoffman MS; Kavanagh JJ; Roberts WS; LaPolla JP; Fiorica JV; Hewitt S; Cavanagh D Gynecol Oncol; 1991 Feb; 40(2):144-6. PubMed ID: 1707024 [TBL] [Abstract][Full Text] [Related]
23. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study. Vrdoljak E; Omrcen T; Novaković ZS; Jelavić TB; Prskalo T; Hrepić D; Hamm W Gynecol Oncol; 2006 Nov; 103(2):494-9. PubMed ID: 16814371 [TBL] [Abstract][Full Text] [Related]
24. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza. Zanetta G; Fei F; Mangioni C Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040 [TBL] [Abstract][Full Text] [Related]
25. Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer: a randomized study. Kumar L; Kaushal R; Nandy M; Biswal BM; Kumar S; Kriplani A; Singh R; Rath GK; Kochupillai V Gynecol Oncol; 1994 Sep; 54(3):307-15. PubMed ID: 7522200 [TBL] [Abstract][Full Text] [Related]
26. [Chemotherapy of cancers of the uterine cervix with a combination of bleomycin, mitomycin, cisplatin and etoposide]. Chauvergne J; Héron JF; Mayer F; Charrot-Chinet P; Toulouse C Bull Cancer; 1993 Jan; 80(1):70-9. PubMed ID: 7515729 [TBL] [Abstract][Full Text] [Related]
27. Combination of consecutive low-dose cisplatin with bleomycin, vincristine, and mitomycin for recurrent cervical carcinoma. Shimizu Y; Akiyama F; Umezawa S; Ishiya T; Utsugi K; Hasumi K J Clin Oncol; 1998 May; 16(5):1869-78. PubMed ID: 9586903 [TBL] [Abstract][Full Text] [Related]
28. Combination chemotherapy with cisplatin and bleomycin in advanced cervical cancer. Bloch B; Nel CP; Kriel A; Atad J; Goldberg G Cancer Treat Rep; 1984 Jun; 68(6):891-3. PubMed ID: 6203640 [TBL] [Abstract][Full Text] [Related]
29. Phase II trial of bleomycin, ifosfamide, and carboplatin in metastatic cervical cancer. Murad AM; Triginelli SA; Ribalta JC J Clin Oncol; 1994 Jan; 12(1):55-9. PubMed ID: 7505808 [TBL] [Abstract][Full Text] [Related]
30. Neoadjuvant bleomycin, ifosfamide and cisplatin in cervical cancer. Tobias J; Buxton EJ; Blackledge G; Mould JJ; Monaghan J; Spooner D; Chetiyawardana A Cancer Chemother Pharmacol; 1990; 26 Suppl():S59-62. PubMed ID: 1693316 [TBL] [Abstract][Full Text] [Related]
31. Etoposide (VP-16), ifosfamide/mesna, and cisplatin chemotherapy for advanced and recurrent carcinoma of the cervix. Kredentser DC Gynecol Oncol; 1991 Nov; 43(2):145-8. PubMed ID: 1743556 [TBL] [Abstract][Full Text] [Related]
32. Retrospective analysis of concurrent chemoradiation with the combination of bleomycin, ifosfamide and cisplatin (BIP) for uterine cervical cancer. Aoki M; Akahira J; Niikura H; Saito S; Abe Y; Aida T; Sato N; Kitamura T; Otsuki K; Katahira A; Utsunomiya H; Okamura C; Takano T; Ito K; Okamura K; Yaegashi N Tohoku J Exp Med; 2004 Dec; 204(4):309-15. PubMed ID: 15572856 [TBL] [Abstract][Full Text] [Related]
33. Bleomycin, mitomycin, and cisplatin therapy for advanced squamous carcinoma of the uterine cervix: a phase II study of the Northern California Oncology Group. Picozzi VJ; Sikic BI; Carlson RW; Koretz M; Ballon SC Cancer Treat Rep; 1985; 69(7-8):903-5. PubMed ID: 2410123 [TBL] [Abstract][Full Text] [Related]
34. Ifosfamide, adriamycin and cisplatin (IAP) plus bleomycin (B) combination chemotherapy in patients with recurrent cancer of the uterine cervix. Nishida T; Nagasue N; Arimatsu T; Nagano H; Izumi S; Okura N; Matsumura T; Yakushiji M Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):590-4. PubMed ID: 2474043 [TBL] [Abstract][Full Text] [Related]
35. [Combination chemotherapy with 254-S, ifosfamide and peplomycin for advanced or recurrent cervical cancer]. Hirabayashi K; Okada E; Nakazuma Y; Akamatsu Y; Sezaki H; Ohta M; Nakanishi Y Nihon Sanka Fujinka Gakkai Zasshi; 1992 Mar; 44(3):341-8. PubMed ID: 1376759 [TBL] [Abstract][Full Text] [Related]
36. A phase II study of weekly cisplatin followed by cisplatin and ifosfamide in advanced or recurrent cervical carcinoma. Rose PG; Piver MS; Malfetano JH; Baker TR; Hempling RE; Recio FO Cancer; 1993 Apr; 71(7):2245-9. PubMed ID: 8453545 [TBL] [Abstract][Full Text] [Related]
37. Cervix carcinoma: treatment with combination cisplatin and bleomycin. Daghestani AN; Hakes TB; Lynch G; Lewis JL Gynecol Oncol; 1983 Dec; 16(3):334-9. PubMed ID: 6197345 [TBL] [Abstract][Full Text] [Related]
38. Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma. Scandurra G; Scibilia G; Banna GL; D'Agate G; Lipari H; Gieri S; Scollo P J Gynecol Oncol; 2015 Apr; 26(2):118-24. PubMed ID: 25686397 [TBL] [Abstract][Full Text] [Related]
39. Combination chemotherapy for patients with advanced carcinoma of the cervix: trial of mitomycin-C, vincristine, bleomycin, and cisplatin. Giannone L; Brenner DE; Jones HW; Greco FA; Burnett LS Gynecol Oncol; 1987 Feb; 26(2):178-82. PubMed ID: 2433196 [TBL] [Abstract][Full Text] [Related]
40. Cisplatin, 5-fluorouracil, and ifosfamide in the treatment of recurrent or advanced cervical cancer. Fanning J; Ladd C; Hilgers RD Gynecol Oncol; 1995 Feb; 56(2):235-8. PubMed ID: 7896191 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]